Found 26 matching trials
The Safety and Efficacy of MK-1293 Versus Lantus⢠in Participants With Type 2 Diabetes Mellitus (MK-1293-006) PHASE3 This 24-week study is a safety and efficacy comparison of MK-1293 and Lantu...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes PHASE3 This trial is conducted in Africa, Asia, Europe and the United States of Am...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Glargine Versus NPH in Patients With Chronic Kidney Disease PHASE4 Chronic kidney disease (CKD) is one of the most common microvascular compli...
Show More Location
University of Sao Paulo
Learn More & Join Trial
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes PHASE3 This trial is conducted in South Africa, Europe and North America. The aim ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents PHASE3 Primary Objective:
* To demonstrate the superiority of Soliqua 100/33 vers...
Show More Location
Investigational Site Number 8400072
Learn More & Join Trial
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes PHASE3 This trial is conducted in Asia and Japan. The aim of this trial is to comp...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes PHASE3 This trial is conducted in Africa, Asia, Europe, and North America. The aim...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005) PHASE1 The purpose of this study is to assess the safety, pharmacokinetics, and ph...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes PHASE3 This trial is conducted in Africa, Asia, Europe, and the United States of A...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes PHASE3 This trial is conducted in Europe and the United States of America (USA). T...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial